Literature DB >> 23836180

Efficacy of ceftaroline fosamil against penicillin-sensitive and -resistant streptococcus pneumoniae in an experimental rabbit meningitis model.

P Cottagnoud1, M Cottagnoud, F Acosta, A Stucki.   

Abstract

Ceftaroline is a new cephalosporin with bactericidal activity against resistant Gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA) and penicillin-resistant Streptococcus pneumoniae, as well as common Gram-negative organisms. This study tested the prodrug, ceftaroline fosamil, against a penicillin-sensitive and a penicillin-resistant strain of S. pneumoniae in an experimental rabbit meningitis model. The penetration of ceftaroline into inflamed meninges was approximately 14%. Ceftaroline fosamil was slightly superior to ceftriaxone against the penicillin-sensitive strain and significantly superior to the combination of ceftriaxone and vancomycin against the penicillin-resistant strain.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23836180      PMCID: PMC3811426          DOI: 10.1128/AAC.00286-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.

Authors:  C M Gerber; M Cottagnoud; K A Neftel; M G Täuber; P Cottagnoud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-12       Impact factor: 3.267

Review 2.  Initial management of acute bacterial meningitis in adults: summary of IDSA guidelines.

Authors:  J David Beckham; Kenneth L Tyler
Journal:  Rev Neurol Dis       Date:  2006

3.  Trends in antimicrobial resistance in Europe: update of EARSS results.

Authors:  M de Kraker; N van de Sande-Bruinsma
Journal:  Euro Surveill       Date:  2007-03-15

4.  Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.

Authors:  C M Gerber; M Cottagnoud; K Neftel; M G Täuber; P Cottagnoud
Journal:  J Antimicrob Chemother       Date:  2000-01       Impact factor: 5.790

5.  Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Authors:  R G Dacey; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

  5 in total
  5 in total

1.  Ceftaroline Cerebrospinal Fluid Penetration in the Treatment of a Ventriculopleural Shunt Infection: A Case Report.

Authors:  Jeffrey J Cies; Wayne S Moore; Adela Enache; Arun Chopra
Journal:  J Pediatr Pharmacol Ther       Date:  2020

2.  Examining the use of ceftaroline in the treatment of Streptococcus pneumoniae meningitis with reference to human cathelicidin LL-37.

Authors:  George Sakoulas; Poochit Nonejuie; Ravina Kullar; Joseph Pogliano; Michael J Rybak; Victor Nizet
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

3.  Ceftaroline fosamil: clinical experience after 23-month prescription in a tertiary hospital.

Authors:  A Alonso Álvarez; L Ramos Merino; L M Castelo Corral; A Padín Trigo; D Sousa Regueiro; E Míguez Rey; E Sánchez Vidal
Journal:  Rev Esp Quimioter       Date:  2021-02-15       Impact factor: 1.553

Review 4.  Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.

Authors:  Susanna Esposito; Timothy J Carrothers; Todd Riccobene; Gregory G Stone; Michal Kantecki
Journal:  Paediatr Drugs       Date:  2021-08-31       Impact factor: 3.022

5.  Endogenous Endophthalmitis From Methicillin-Resistant Staphylococcus aureus Bacteremia Treated With Ceftaroline.

Authors:  Daniel Ho; Nicola A Clayton; Bruce Silverstein; Alan Koff
Journal:  Cureus       Date:  2022-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.